A 67-year-old man on long-term carbamazepine therapy underwent elective coronary artery bypass grafting. Following an initially uncomplicated recovery, he developed symptomatic hyponatremia. The symptoms and biochemical abnormality improved after gradual discontinuation of carbamazepine. We discuss the association between carbamazepine and hyponatremia and the causes of hyponatremia after cardiopulmonary bypass. Surgeons should consider stopping carbamazepine before operations with cardiopulmonary bypass.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1046/j.1540-8191.2003.02013.x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!